Currently out of the existing stock ratings of Jeff Garro, 80 are a BUY (67.8%), 37 are a HOLD (31.36%), 1 are a SELL (0.85%).

Jeff Garro

Work Performance Price Targets & Ratings Chart

Analyst Jeff Garro, currently employed at STEPHENS, carries an average stock price target met ratio of 39.07% that have a potential upside of 19.41% achieved within 158 days.

Jeff Garro’s has documented 229 price targets and ratings displayed on 16 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on CERT, Certara at 12-May-2026.

Wall Street Analyst Jeff Garro

Analyst best performing recommendations are on HCAT (HEALTH CATALYST).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 8/8/2024. The price target of $7 was fulfilled within 1 day with a profit of $0.55 (7.28%) receiving and performance score of 72.85.

Average potential price target upside

of $44.04 (21.07%) on IQV (IQVIA HOLDINGS).
of $10.82 (14.51%) on CERN (CERNER CORP).
of $6.82 (42.78%) on NXGN (NEXTGEN HEALTHCARE).

APR Apria BHG Bright Health Group INNV InnovAge Holding Corp SLQT Selectquote ALHC Alignment Healthcare LLC IQV IQVIA Holdings MDRX Allscripts Healthcare Solutions NXGN Nextgen Healthcare ACCD Accolade CERN Cerner Corp CERT Certara CPSI Computer Programs and Systems OPRX OPTIMIZERx Corp PHR Phreesia TDOC Teladoc FIT Fitbit

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Ralph Giacobbe